EP3574309A4 - Immunodosage à base de particules magnétiques et ses procédés d'utilisation - Google Patents

Immunodosage à base de particules magnétiques et ses procédés d'utilisation Download PDF

Info

Publication number
EP3574309A4
EP3574309A4 EP18744906.1A EP18744906A EP3574309A4 EP 3574309 A4 EP3574309 A4 EP 3574309A4 EP 18744906 A EP18744906 A EP 18744906A EP 3574309 A4 EP3574309 A4 EP 3574309A4
Authority
EP
European Patent Office
Prior art keywords
methods
same
magnetic particle
based immunoassay
immunoassay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18744906.1A
Other languages
German (de)
English (en)
Other versions
EP3574309A1 (fr
Inventor
Andrew Ward
Arun Richard CHANDRASEKARAN
Daniel Chen
Christopher Blanchard
Padric GARDEN
Bradley DEMARCO
Joshua Forman
Mounir A. KOUSSA
Lisa CALDWELL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vital Biosciences Inc
Original Assignee
Vital Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vital Biosciences Inc filed Critical Vital Biosciences Inc
Publication of EP3574309A1 publication Critical patent/EP3574309A1/fr
Publication of EP3574309A4 publication Critical patent/EP3574309A4/fr
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
EP18744906.1A 2017-01-26 2018-01-26 Immunodosage à base de particules magnétiques et ses procédés d'utilisation Pending EP3574309A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762450623P 2017-01-26 2017-01-26
US201762544393P 2017-08-11 2017-08-11
PCT/US2018/015440 WO2018140719A1 (fr) 2017-01-26 2018-01-26 Immunodosage à base de particules magnétiques et ses procédés d'utilisation

Publications (2)

Publication Number Publication Date
EP3574309A1 EP3574309A1 (fr) 2019-12-04
EP3574309A4 true EP3574309A4 (fr) 2020-11-11

Family

ID=62978769

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18744906.1A Pending EP3574309A4 (fr) 2017-01-26 2018-01-26 Immunodosage à base de particules magnétiques et ses procédés d'utilisation

Country Status (4)

Country Link
EP (1) EP3574309A4 (fr)
CN (1) CN110462383A (fr)
CA (1) CA3051475A1 (fr)
WO (1) WO2018140719A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220260557A1 (en) * 2018-07-27 2022-08-18 Veravas, Inc. Methods for depletion and enrichment
CN112415184A (zh) * 2019-08-22 2021-02-26 香港科技大学 用于细胞群体和单细胞的单分子分离系统及其方法和用途
CN110618265B (zh) * 2019-09-12 2023-04-18 广东省药品检验所（广东省药品质量研究所、广东省口岸药品检验所） 一种沙丁胺醇的可视化检测方法
CN111024938B (zh) * 2019-11-27 2023-05-26 武汉市农业科学院 一种病原微生物快速检测方法
GB202006800D0 (en) * 2020-05-07 2020-06-24 Cambridge Entpr Ltd Carrier system and method
CN116391126A (zh) * 2020-08-07 2023-07-04 维塔生物科技公司 磁性分析物检测的动力学调节
WO2022029731A1 (fr) * 2020-08-07 2022-02-10 Vital Biosciences Inc. Détection d'analyte multiplexée
GB202019024D0 (en) * 2020-12-02 2021-01-13 Paraytec Ltd Diagnostic testing
CN112710858A (zh) * 2020-12-15 2021-04-27 深圳天辰医疗科技有限公司 试剂盒及其制备方法和应用
CN112526121B (zh) * 2020-12-18 2022-11-18 深圳普门科技股份有限公司 血清淀粉样蛋白a检测试剂盒及其检测系统
CN112748096B (zh) * 2020-12-29 2022-03-18 山西大学 一种磺胺二甲氧嘧啶的室温磷光检测方法及应用
CN112763484B (zh) * 2021-01-27 2022-05-03 南京医科大学 一种基于比色生物传感器检测谷胱甘肽和/或过氧化氢的方法
CN113373156A (zh) * 2021-06-30 2021-09-10 四川携光生物技术有限公司 自身免疫性脑炎相关的nmdar重组蛋白、其编码序列、制法和应用
CN114152741B (zh) * 2021-11-18 2022-08-19 上海北昂医药科技股份有限公司 一种提高有效微珠比例的dELISA样品及其制备与检测方法
CN113960313B (zh) * 2021-12-22 2022-04-12 上海思路迪医学检验所有限公司 一种外泌体alk融合蛋白磁免疫化学发光检测试剂盒
CN114706023A (zh) * 2022-06-06 2022-07-05 中国科学技术大学 生物分子相互作用的磁学检测方法
WO2024102748A1 (fr) * 2022-11-07 2024-05-16 Kephera Diagnostics, Llc Méthodes, instruments de diagnostic et kits de détection de maladies
CN115815588B (zh) * 2022-11-30 2024-06-28 山东省淡水渔业研究院（山东省淡水渔业监测中心） 基于纳米钯/多层空心球状Pd/CuO@NiO检测水产品中孔雀石绿的方法
WO2024175169A1 (fr) * 2023-02-20 2024-08-29 STILLER, Olaf Procédé permettant de détecter directement la présence d'une substance de test

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110065209A1 (en) * 2009-08-31 2011-03-17 Mbio Diagnostics, Inc. Integrated Sample Preparation and Analyte Detection
WO2013189502A1 (fr) * 2012-06-22 2013-12-27 Scandinavian Micro Biodevices Aps Procédé et système permettant la détermination quantitative ou qualitative d'un composé cible
US20140170767A1 (en) * 2012-11-30 2014-06-19 Korea Institute Of Science And Technology Method for diagnosing biomarkers and biomarker diagnosis kit

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541617B1 (en) * 1998-10-27 2003-04-01 Clinical Micro Sensors, Inc. Detection of target analytes using particles and electrodes
US6607922B2 (en) * 2000-03-17 2003-08-19 Quantum Design, Inc. Immunochromatographic assay method and apparatus
CN100420947C (zh) * 2005-05-30 2008-09-24 孙东旭 用单一捕获剂定量检测特异性分析物的方法及其试剂盒
JP5200003B2 (ja) * 2006-05-09 2013-05-15 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 磁場を用いた試料中の標的分子の検出
US8873038B2 (en) * 2010-10-27 2014-10-28 The Board Of Trustees Of The University Of Illinois Tailored raman spectrocopic probes for ultrasensitive and highly multiplexed assays
EP2629095A1 (fr) * 2012-02-17 2013-08-21 Biosure R & T Cell Co. Détection de cibles de protéine mycobactérienne incluant des points Quantum et séparation immunomagnétique
US9599610B2 (en) * 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
US9891227B2 (en) * 2014-05-02 2018-02-13 Academia Sinica Ultrasensitive detection of a biological target by aptamer-conjugated gold nanoparticles

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110065209A1 (en) * 2009-08-31 2011-03-17 Mbio Diagnostics, Inc. Integrated Sample Preparation and Analyte Detection
WO2013189502A1 (fr) * 2012-06-22 2013-12-27 Scandinavian Micro Biodevices Aps Procédé et système permettant la détermination quantitative ou qualitative d'un composé cible
US20140170767A1 (en) * 2012-11-30 2014-06-19 Korea Institute Of Science And Technology Method for diagnosing biomarkers and biomarker diagnosis kit

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2018140719A1 *

Also Published As

Publication number Publication date
CN110462383A (zh) 2019-11-15
CA3051475A1 (fr) 2018-08-02
WO2018140719A1 (fr) 2018-08-02
EP3574309A1 (fr) 2019-12-04

Similar Documents

Publication Publication Date Title
EP3574309A4 (fr) Immunodosage à base de particules magnétiques et ses procédés d'utilisation
EP3723803A4 (fr) Anticorps anti-trem2 et méthodes associées
EP3515478A4 (fr) Anticorps pour siglec-15 et leurs méthodes d'utilisation
EP3572427A4 (fr) Anticorps ciblant bcma et son utilisation
EP3504243A4 (fr) Anticorps anti-tim-3 et leurs utilisations
EP3383430A4 (fr) Anticorps et leurs méthodes d'utilisation
EP3634430A4 (fr) Agents multibiotiques et procédés d'utilisation de ceux-ci
EP3454900A4 (fr) Anticorps cd47 et leurs méthodes d'utilisation
EP3383431A4 (fr) Anticorps anti-gitr et leurs méthodes d'utilisation
EP3280441A4 (fr) Anticorps anti-sortiline et leurs méthodes d'utilisation
IL276515A (en) Antibodies specific to PD-L1 and methods of using them
EP3852805A4 (fr) Anticorps anti-lilrb2 et leurs méthodes d'utilisation
EP3684821A4 (fr) Anticorps anti-hla-a2 et leurs procédés d'utilisation
EP3525583A4 (fr) Anticorps anti-c1s et leurs méthodes d'utilisation
EP3383917A4 (fr) Nouveaux anticorps anti-claudine et méthodes d'utilisation
EP3436476A4 (fr) Anticorps anti-ryk et leurs procédés d'utilisation
EP3675906A4 (fr) Anticorps anti-tm4sf1 et leurs procédés d'utilisation
EP3728323A4 (fr) Anticorps anti-fzd et méthodes d'utilisation
EP3684819A4 (fr) Anticorps anti-ykl40 et méthodes d'utilisation
EP3559042A4 (fr) Anticorps anti-lilrb3 et leurs procédés d'utilisation
EP3625253A4 (fr) Anticorps activables et leurs procédés d'utilisation
EP3733702A4 (fr) Anticorps anti-lag-3 et utilisations associées
EP3710589A4 (fr) Anticorps anti-c1s et procédés d'utilisation
EP3567054A4 (fr) Anticorps anti-alpha-syn et son utilisation
EP3731867A4 (fr) Anticorps anti-lrp5/6 et leurs procédés d'utilisation

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190730

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: G01N0021760000

Ipc: G01N0033553000

A4 Supplementary search report drawn up and despatched

Effective date: 20201012

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/553 20060101AFI20201006BHEP

Ipc: G01N 33/543 20060101ALI20201006BHEP

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230515

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230714